The reactive stroma microenvironment and prostate cancer progression
Open Access
- 28 August 2012
- journal article
- review article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 19 (6), R187-R204
- https://doi.org/10.1530/erc-12-0085
Abstract
Reactive stroma initiates during early prostate cancer development and coevolves with prostate cancer progression. Previous studies have defined the key markers of reactive stroma and have established that reactive stroma biology influences prostate tumorigenesis and progression. The stem/progenitor cells of origin and the mechanisms that regulate their recruitment and activation to myofibroblasts or carcinoma-associated fibroblasts are essentially unknown. Key regulatory factors have been identified, including transforming growth factor β, interleukin-8, fibroblast growth factors, connective tissue growth factor, wingless homologs-Wnts, and stromal cell-derived factor-1, among others. The biology of reactive stroma in cancer is similar to the more predictable biology of the stroma compartment during wound repair at sites where the epithelial barrier function is breached and a stromal response is generated. The coevolution of reactive stroma and the biology of how reactive stroma–carcinoma interactions regulate cancer progression and metastasis are targets for new therapeutic approaches. Such approaches are strategically designed to inhibit cancer progression by uncoupling the reactive stroma niche.Keywords
This publication has 164 references indexed in Scilit:
- The functional role of reactive stroma in benign prostatic hyperplasiaDifferentiation, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Transforming growth factor beta (TGF-β) and inflammation in cancerCytokine & Growth Factor Reviews, 2009
- Lymphocytes in cancer development: Polarization towards pro-tumor immunityCytokine & Growth Factor Reviews, 2009
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Tumor‐promoting phenotype of CD90hi prostate cancer‐associated fibroblastsThe Prostate, 2009
- Keratinocyte‐derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse modelThe Prostate, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Role of the stromal microenvironment in carcinogenesis of the prostateInternational Journal of Cancer, 2003